Skip to main content

MoneyWorks4Me

Parmax Pharma inks pact with CHL for production of intermediates of ‘Hydroxy chloroquine’

27 Apr 2020 Evaluate

Parmax Pharma has entered into Confidentiality Agreement with Cadila Healthcare (CHL), Ahmedabad for production of intermediates of ‘Hydroxy chloroquine’ (Product) on the basis of process and specifications provided by the CHL. Currently, company is reviewing the business and taking trial batches of the product.

Parmax Pharma carries on business as manufacturers, producers, refiners, mixers, processors, repackers, distillers, formulators, convertors, extractors, buyers, sellers, wholesalers, retailers, distributors, suppliers, importers, extractors, or otherwise to deal in all kinds of drug and drugs used in pharmaceutical.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..